Moderna's vax approved for younger children

A second COVID-19 vaccine for ages 6-11 'welcomed' as a way to boost uptake

Another COVID-19 vaccine will soon be available for younger children with the TGA’s provisional approval of Moderna’s Spikevax for those aged six and over. 

Associate Professor Paul Griffin.

The provisional approval follows “careful consideration” of US and Canadian vaccine trials, the watchdog said in a statement.

Data showed the immune response and safety profile in children was